Tuesday, January 18, 2011

A Pink-Ribbon Race, Years Long (NY Times article)

This recent NY Times article has me on a roller coaster of emotion. I don't know whether to like it or hate it.

I like it because it resonates so well with many of my own thoughts and feelings.  I can relate to so many of the sentiments and frustrations expressed.  It doesn't just paint breast cancer as a cliche pink ribbon... of course, I hate it for many of the same reasons.  Because it is so painfully and terrifyingly true.

Despite the great strides we have made in awareness and in removing the stigma associated with breast cancer, we have done very little to impact the number of people dying from breast cancer.  The funding for breast cancer research is still 95% focused on early stage disease.  There is more we can do.  There is more we must do.

The article can be found in it's entirety here: http://www.nytimes.com/2011/01/18/health/18cancer.html.   Below is a summary of how well the article describes my own personal sentiments (items in bold are my thoughts and those in italics are direct quotes from the article)


I am a breast cancer advocate but I am frustrated with the sea of pink ribbon waving survivors and the lack of awareness of and focus on curing Stage IV disease

“All too often, when people think about breast cancer, they think about it as a problem, it’s solved, and you lead a long and normal life; it’s a blip on the curve,” he said. “While that’s true for many people, each year approximately 40,000 people die of breast cancer — and they all die of metastatic disease. You can see why patients with metastatic disease may feel invisible within the advocacy community.

"While perceptions of the disease may have changed in recent years, the number of deaths it causes has remained fairly static, said Dr. Eric P. Winer, director of the breast oncology center at the Dana-Farber Cancer Institute in Boston."
Dr. Hebert says that while the pink-ribbon campaign has raised awareness about breast cancer, it masks a relentless killer. “People like the pretty story with the happy ending,” she said. “We don’t have the happy ending. “
[Metastatic cancer is] responsible for 90 percent of the morbidity and mortality, but gets less than 5 percent of the budget,” said Dr. Welch, a senior scientist at the Comprehensive Cancer Center at the University of Alabama at Birmingham, who studies genes that suppress metastasis. (Those genes are turned off when cancer is advanced.) “Funding agencies as a rule want to say their research portfolio is successful — they want a return on their investment very quickly.”
I am living life in 3 month segments... unable to plan anything further out than that
But theirs are not pink-ribbon lives: They live from scan to scan, in three-month gulps, grappling with pain, fatigue, depression, crippling medical costs and debilitating side effects of treatment, hoping the current therapy will keep the disease at bay until the next breakthrough drug comes along, or at least until the family trip to Disney World.
This kind of uncertainty keeps many patients from throwing themselves wholeheartedly into the ethos of hope and empowerment that helps sustain many women with less aggressive forms of the disease.

While there is a ton of support out there for breast cancer, I find it difficult to find a support network because I am every "early stage survivors" worst nightmare
Still, Dr. Hebert, an optometrist in South Windsor, Conn., went to her first support group meeting thinking that as bad as things were, at least breast cancer was not an obscure disease; she would not be alone.
But the room was filled with women who had early localized cancers. Some had completed chemotherapy years ago; they were “survivors.” When one newcomer asked Dr. Hebert for her story, she couldn’t bring herself to tell the truth.


"This woman had just been diagnosed,” Dr. Hebert said of her support-group encounter, “and I couldn’t bring myself to tell her: ‘I have it in my bones. I have it in several parts of my body. My treatment is never going to end.’
“It was a horrible moment,” she went on. “I had nothing in common with them. I was what scared them.”
Recent events have begun to illuminate the battle still left to be fought... and there is definitely hope to be had and successes to be celebrated

Mrs. Edwards’s 2007 announcement that her cancer had become “incurable” was an inspiration to many — it was also why her death was such a blow. “She put a face on the disease,” Dr. Hebert said. “I could explain my situation to people.


New drug treatments are keeping some patients alive for a decade or more, even after the disease has spread. And they can enjoy a higher quality of life than patients did in the past, because treatments are better focused and have fewer side effects.
“Over the past 20 years, we’ve had probably 15 new drugs approved by the F.D.A., and each of them adds an incremental amount to the length of life, “ said Dr. Gabriel N. Hortobagyi, director of the breast cancer research program at M. D. Anderson Cancer Center in Houston.
“I would never tell a patient with a newly diagnosed metastasis that there is nothing I can do,” he said, “because there are actually dozens of things I can do ... and there are many things we can do to control symptoms and prevent complications.”
 Depending on the type of tumor, patients may live for many years — working, raising children, starting nonprofit foundations, doing yoga and even running half-marathons.
Nevertheless, at the end of the day, breast cancer is still a b#%ch

The average patient may receive eight or 10 different treatment regimens in sequence, he said.
 
Stage 4 breast cancer can be treated, but it is considered incurable.
“You always hear stories about women who ‘battled it’ and ‘how courageous’ they were. Cancer doesn’t care if you’re courageous. It’s an injustice to all of us who have this. There are women who are no less strong and no less determined to be here, and they’ll be dead in two years.”

No comments:

Post a Comment